Brendel Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-648
Closed -$313K 63
2022
Q2
$313K Sell
648
-160
-20% -$79.2K 0.27% 73
2022
Q1
$397K Buy
+808
New +$369K 0.22% 79
2021
Q3
Sell
-562
Closed -$215K 132
2021
Q2
$215K Buy
+562
New +$215K 0.12% 106
2019
Q1
Sell
-4,377
Closed -$1.15M 79
2018
Q4
$1.15M Buy
+4,377
New +$1.2M 1.32% 34

Other funds holding ELV

Brendel Financial Advisors's ELV Position: Q3 2022 in Review

Brendel Financial Advisors sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 648 shares — an estimated $313K sold.

Brendel Financial Advisors first reported a position in ELV in Q4 2018 and held it in 4 quarters. The position peaked at $1.15M in Q4 2018. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Brendel Financial Advisors reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Brendel Financial Advisors sold 648 Elevance Health shares in Q3 2022, an estimated $313K.
  • Brendel Financial Advisors first reported a position in Elevance Health in Q4 2018 and held it in 4 quarters.
  • Brendel Financial Advisors's Elevance Health position peaked at $1.15M in Q4 2018.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Brendel Financial Advisors's 13F filing for Q3 2022, filed 11 Oct 2022.